| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.072 | 0.7 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.074 | 0.7 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |